Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125345-25-000108
Filing Date
2025-11-12
Accepted
2025-11-12 16:04:23
Documents
62
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgnx-20250930.htm   iXBRL 10-Q 936911
2 EX-31.1 exhibit31-1q32025.htm EX-31.1 8937
3 EX-31.2 exhibit31-2q32025.htm EX-31.2 8930
4 EX-32.1 exhibit32-1q32025.htm EX-32.1 3921
5 EX-32.2 exhibit32-2q32025.htm EX-32.2 3777
  Complete submission text file 0001125345-25-000108.txt   5586353

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250930.xsd EX-101.SCH 40897
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgnx-20250930_cal.xml EX-101.CAL 49211
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgnx-20250930_def.xml EX-101.DEF 216230
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20250930_lab.xml EX-101.LAB 548593
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20250930_pre.xml EX-101.PRE 384106
64 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250930_htm.xml XML 725366
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36112 | Film No.: 251472544
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)